Parameter | Cancer (n = 20) Mean ± SD | Controls (n = 36) Mean ± SD | p-value |
mREE | 1596.8 ± 212.1 | 1421.9 ± 153.1 |  < 0.001* |
mREE/FFM | 34.4 ± 4.8 | 31.0 ± 3.0 |  < 0.001* |
mREE/pREE | 15.8 ± 9.2 | 2.5 ± 7.0 |  < 0.001* |
BW | 70.1 ± 5.9 | 70.4 ± 13.8 | 0.906 |
FFMkg | 46.6 ± 4.6 | 46.1 ± 5.4 | 0.812 |
FFM% | 66.8 ± 6.6 | 65.1 ± 11.8 | 0.966 |
FMkg | 24.2 ± 7.2 | 26.0 ± 13.6 | 0.915 |
FM% | 33.2 ± 6.6 | 33.3 ± 8.5 | 0.497 |
Effects of 12Â weeks of chemotherapy energy expenditure and body composition in patients with breast cancer | |||
Parameter | Baseline (T0; n = 14) Mean ± SD | Follow-up (T1; n = 14) Mean ± SD | p-value |
mREE | 1596.8 ± 212.1 | 1524.0 ± 230.9 | 0.174 |
mREE/FFM | 34.4 ± 4.8 | 33.8 ± 4.2 | 0.628 |
mREE/pREE | 15.8 ± 9.2 | 9.8 ± 13.8 | 0.084 |
BW | 70.1 ± 5.9 | 71.7 ± 5.2 | 0.204 |
FFMkg | 46.6 ± 4.6 | 45.1 ± 3.9 | 0.006* |
FFM% | 66.8 ± 6.6 | 63.6 ± 3.9 | 0.028* |
FMkg | 24.2 ± 7.2 | 25.9 ± 4.0 | 0.208 |
FM% | 33.2 ± 6.6 | 39.6 ± 8.6 | 0.027* |